Editorial: Challenges in developing new multiple sclerosis therapies per Michael K. Racke

Obtenir text complet

Natalizumab: increased vigilance is required in treating patients with multiple sclerosis per Michael K. Racke, Olaf Stüve

Obtenir text complet

PPARs in Neuroinflammation per Paul D. Drew, Michael K. Racke

Obtenir text complet

Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management Through Clinical Vignettes per Michael K. Racke, Elliot M. Frohman, Teresa Frohman

Obtenir text complet

Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARs per Yuhong Yang, Amy E. Lovett-Racke, Michael K. Racke

Obtenir text complet

PPAR Alpha Regulation of the Immune Response and Autoimmune Encephalomyelitis per Michael K. Racke, Paul D. Drew, Amy Lovett-Racke, Yuhong Yang, Anne R. Gocke

Obtenir text complet

Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patients. per Karen Yao, Susan Gagnon, Nahid Akhyani, Elizabeth Williams, Julie Fotheringham, Elliot Frohman, Olaf Stuve, Nancy Monson, Michael K Racke, Steven Jacobson

Obtenir text complet

PEG minocycline-liposomes ameliorate CNS autoimmune disease. per Wei Hu, Josbert Metselaar, Li-Hong Ben, Petra D Cravens, Mahendra P Singh, Elliot M Frohman, Todd N Eagar, Michael K Racke, Bernd C Kieseier, Olaf Stüve

Obtenir text complet

A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:Treg balance per Saba I. Aqel, Xiaozhi Yang, Emma E. Kraus, Jinhua Song, Marissa F. Farinas, Erin Y. Zhao, Wei Pei, Amy E. Lovett-Racke, Michael K. Racke, Chenglong Li, Yuhong Yang

Obtenir text complet

Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis. per Nancy L Monson, Petra Cravens, Rehana Hussain, Christopher T Harp, Matthew Cummings, Maria de Pilar Martin, Li-Hong Ben, Julie Do, Jeri-Anne Lyons, Amy Lovette-Racke, Anne H Cross, Michael K Racke, Olaf Stüve, Mark Shlomchik, Todd N Eagar

Obtenir text complet

Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer’s disease assessment per Darren M. Weber, Steven W. Taylor, Robert J. Lagier, Jueun C. Kim, Scott M. Goldman, Nigel J. Clarke, David E. Vaillancourt, Ranjan Duara, Ranjan Duara, Karen N. McFarland, Wei-en Wang, Todd E. Golde, Todd E. Golde, Michael K. Racke

Obtenir text complet

K27-linked RORγt ubiquitination by Nedd4 potentiates Th17-mediated autoimmunity per Qiuming Zeng, Hui Guo, Na Tang, Pranav S. Renavikar, Nitin J. Karandikar, Amy E. Lovett-Racke, Michael K. Racke, Chengkai Yan, Rong Tang, Sushmita Sinha, Krishnendu Ghosh, Jeremy P. Ryal, Song Ouyang, Min Chen, Foued Amari, Coppola Vincenzo, R. Marshall Pope, Yalan Li, Huan Yang, Wallace Y. Langdon, Jian Zhang

Obtenir text complet

A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple scler... per Elliot M. Frohman, Gary Cutter, Gina Remington, Hongjiang Gao, Howard Rossman, Bianca Weinstock-Guttman, Jacqueline E. Durfee, Amy Conger, Ellen Carl, Katherine Treadaway, Eric Lindzen, Amber Salter, Teresa C. Frohman, Anjali Shah, Angela Bates, Jennifer L. Cox, Michael G. Dwyer, Olaf Stuve, Benjamin M. Greenberg, Michael K. Racke, Robert Zivadinov

Obtenir text complet

Prior cycles of anti-CD20 antibodies affect antibody responses after repeated SARS-CoV-2 mRNA vaccination per Hiromitsu Asashima, Dongjoo Kim, Kaicheng Wang, Nikhil Lele, Nicholas C. Buitrago-Pocasangre, Rachel Lutz, Isabella Cruz, Khadir Raddassi, William E. Ruff, Michael K. Racke, JoDell E. Wilson, Tara S. Givens, Alba Grifoni, Daniela Weiskopf, Alessandro Sette, Steven H. Kleinstein, Ruth R. Montgomery, Albert C. Shaw, Fangyong Li, Rong Fan, David A. Hafler, Mary M. Tomayko, Erin E. Longbrake

Obtenir text complet